Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
AGC ( (JP:5201) ) has shared an announcement.
AGC Inc. has revised its financial forecasts for the fiscal year ending December 31, 2025, citing a decrease in net sales and operating profit due to production issues in its biopharmaceuticals CDMO business, lower PVC sales prices, and reduced sales volume of semiconductor-related products. The company also anticipates lower profits due to impairment losses from structural reforms at its Boulder and Longmont sites in Colorado, USA. Despite these challenges, the dividends forecast remains unchanged.
The most recent analyst rating on (JP:5201) stock is a Hold with a Yen4700.00 price target. To see the full list of analyst forecasts on AGC stock, see the JP:5201 Stock Forecast page.
More about AGC
AGC Inc. operates in the chemicals industry, providing products and services across various segments including life sciences, chemicals, and electronics. The company focuses on biopharmaceuticals, PVC, and semiconductor-related products.
Average Trading Volume: 1,066,251
Technical Sentiment Signal: Buy
Current Market Cap: Yen950.3B
For detailed information about 5201 stock, go to TipRanks’ Stock Analysis page.